MIDTOWN, Manhattan (WABC) -- The controversy over the cost of the potentially life saving drug Epipen is growing. On Monday drugmaker Mylan announced it will offer a generic version of its allergy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback